Argentina vs Congo: The number of people with susceptibility test result for rifampicin
Argentina
2,309
in 2021
Congo
2,015
in 2021
Argentina rank
44th
Congo rank
47th
The number of people with susceptibility test result for rifampicin over time
- Argentina
- Congo
How they compare
Argentina currently reports 2,309 against 2,015 in Congo, a difference of 294.
That makes Argentina's figure about 1.1 times Congo's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Argentina ahead.
Argentina ranks 44th and Congo ranks 47th of 155 countries.
Across the 2 decades both report, Argentina averaged higher in 1 and Congo in 1.
Head to head by decade
| Decade | Argentina | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,204 | 621 | 583.33 | Argentina |
| 2020s | 1,732 | 3,055 | 1,323 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Argentina or Congo?
- Argentina, at 2,309 against 2,015 in Congo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Argentina and Congo?
- 294, with Argentina ahead.
- How many years of comparable data are there for Argentina and Congo?
- 5 years are reported by both, from 2017 to 2021.
- How do Argentina and Congo rank globally for the number of people with susceptibility test result for rifampicin?
- Argentina ranks 44th and Congo ranks 47th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.